DPMAregister | Patents - ST.27-legal status data

ST.27-legal status data

The legal status information displayed below is based on WIPO Standard ST.27 and of a purely informative nature. Binding information on the status of the IP right is only available in DPMAregister (Show details).

DE file number: 603 46 915.9, EP file number: 09 00 8756.0 (Designation/title: Pharmazeutische Zusammensetzungen zur Behandlung von Krebs)

↩ Details

Tabular representation
Current state: Not active, Current state: Termination likely/termination

Key event history
No.	Key Event Code	Key Event Name	Event Date	Effective Date	Publication Date	To Stage
1	Q10	Document published	Sep 30, 2009	Sep 30, 2009		Filing
2	Q10	Document published	Sep 30, 2009	Sep 30, 2009		Filing
3	Q10	Document published	Nov 12, 2009	Nov 12, 2009	Nov 12, 2009	Filing
4	Q10	Document published	Oct 22, 2014	Oct 22, 2014		Examination
5	Q10	Document published	Dec 4, 2014	Dec 4, 2014	Dec 4, 2014	Examination
6	E10	Pre-grant review requested	Jul 14, 2015	Jul 14, 2015	Sep 24, 2015	Pre-grant challenge
7	B10	Application discontinued	Dec 19, 2016	Dec 19, 2016	Aug 17, 2017	Termination likely/termination

Detailed event history
No.	Detailed Event Code	Detailed Event Name	Event Date	Effective Date	Publication Date	To Stage
1	Q12	Application published	Sep 30, 2009	Sep 30, 2009		Filing
2	Q10	Document published	Sep 30, 2009	Sep 30, 2009		Filing
3	Q10	Document published	Nov 12, 2009	Nov 12, 2009	Nov 12, 2009	Filing
4	P22	Classification modified	May 22, 2014	May 22, 2014		Filing
5	Q10	Document published	Oct 22, 2014	Oct 22, 2014		Examination
6	Q10	Document published	Dec 4, 2014	Dec 4, 2014	Dec 4, 2014	Examination
7	E11	Pre-grant opposition filed	Jul 14, 2015	Jul 14, 2015	Sep 24, 2015	Pre-grant challenge
8	B17	Application discontinued following pre-grant review	Dec 19, 2016	Dec 19, 2016	Aug 17, 2017	Termination likely/termination

Graphical representation

Below you will see a simplified graphical representation of the legal status information, which is based on WIPO Standard ST.27 using the "Overall Patent/SPC Prosecution Model" defined therein.